report
observ
patient
confirm
symptomatolog
compar
control
subject
brief
notabl
cytopoenia
record
flow
cytometri
popul
significantli
yet
invers
correl
remark
increas
serum
level
proinflammatori
cytokin
tnfa
flow
cytometri
establish
progress
increas
express
program
cell
death
cell
immunoglobulin
mucin
domain
patient
deterior
prodrom
symptomat
requir
intens
care
interpret
observ
diao
et
al
current
understand
cell
immunophysiolog
immunopatholog
follow
immun
challeng
form
sustain
viral
infect
case
emphasi
exhaust
cell
tex
recent
clinic
trial
rescu
tex
show
promis
outcom
relev
intervent
prevent
treatment
discuss
taken
togeth
data
diao
et
al
could
proffer
first
glimps
immunopatholog
possibl
immunotherapi
patient
normal
healthi
subject
peripher
blood
lymphocyt
cell
express
cell
receptor
tcr
associ
cluster
differenti
two
princip
popul
cell
express
either
moeiti
cell
recogn
nonself
present
major
histocompat
complex
mhc
class
ii
myeloid
cell
dendrit
cell
special
antigenpres
cell
step
accompani
product
cytokin
certain
immun
factor
favor
immun
cell
prolifer
cytokin
produc
step
typic
enhanc
inflammatori
process
informat
recogn
proinflammatori
cytokin
includ
interleukin
il
other
upon
present
nonself
antigen
mhcii
two
critic
bind
event
must
occur
engag
product
cell
activ
lead
prolifer
aid
proinflammatori
cytokin
cell
prolifer
factor
produc
activ
cell
bind
event
engag
tcr
secondari
activ
site
trigger
tcr
alon
lead
unproduct
activ
engend
activ
prolifer
lack
thereof
known
anergi
trigger
alon
signal
cell
faulti
activ
lead
program
cell
death
apoptosi
contrast
cell
recogn
nonself
present
mhci
transform
viral
infect
cell
step
also
accompani
proinflammatori
cytokin
storm
although
predomin
one
interferon
famili
ifn
eg
counterpart
cell
activ
success
product
tcr
engag
lest
lead
either
anergi
apoptosi
outlin
cell
often
recogn
helper
popul
product
prolifer
lead
activ
matur
b
cell
gener
antibodi
contain
neutral
bacteri
parasit
antigen
cell
orchestr
cytotox
respons
viral
cancer
antigen
third
popul
cell
suppress
prolif
respons
activ
lymphocyt
call
regulatori
cell
treg
treg
express
moieti
although
treg
also
cell
treg
express
marker
tregcel
activ
antigenspecif
impli
suppress
activ
treg
cell
antigendepend
certain
cytokin
eg
enhanc
treg
therefor
dampen
cell
activ
brief
cell
respons
normal
state
fine
balanc
set
event
orchestr
three
princip
popul
reactiv
cell
effector
effector
treg
cytokin
storm
correspond
antigenpres
cell
produc
whether
activ
cell
engag
product
prolifer
matur
unproduct
anergi
selfimpos
program
cell
death
determin
certain
specif
receptorand
coreceptorligand
interact
cell
antigenpres
cell
includ
ligand
togeth
process
ensur
proper
dynam
unfold
event
complex
yet
homeostat
immunophysiolog
environ
tradit
canon
immun
mechan
relat
immunoregulatori
mechan
describ
elsewher
converg
maintain
organ
state
immuno
physiolog
balanc
challeng
antigen
specif
seri
coordin
heterostasi
event
engag
drive
organ
regain
homeostasi
collect
immunophysiolog
adapt
event
repres
immun
allostasi
character
laboratori
evid
point
statist
model
algorithm
inform
artifici
model
ai
cellmedi
immun
surveil
implic
contain
epidem
ebola
viru
dengu
viru
zika
viru
h
na
influenza
viru
well
sar
mer
context
futur
immun
surveil
within
translat
healthcar
discuss
elsewher
time
critic
determin
similar
ai
algorithm
also
develop
recent
work
cellular
immunolog
uncov
highgrad
chronic
viral
infect
cell
sustain
longterm
activ
enter
stage
exhaust
antigen
specif
equal
prone
exhaust
differenti
cell
exhaust
silenc
cell
respons
observ
across
host
even
within
host
exhaust
cell
tex
epitopespecif
differ
distinct
anerg
cell
highgrad
chronic
viral
infect
may
may
lead
deplet
specif
tex
subpopul
via
apoptosi
tex
express
certain
specif
marker
includ
program
cell
death
cell
immunoglobulin
mucin
either
produc
modul
certain
cytokin
includ
tex
cell
character
progress
loss
effector
function
high
sustain
inhibitori
receptor
express
metabol
dysregul
poor
memori
homeostat
selfrenew
distinct
transcript
epigenet
program
express
critic
checkpoint
cell
exhaust
sever
biomark
tex
inde
vitro
blockad
administr
overid
inhibitori
signal
revers
cell
exhaust
experiment
set
brief
tex
heterogen
includ
progenitor
termin
subset
uniqu
characterist
respons
checkpoint
blockad
highgrad
chronic
viral
infect
persist
tumor
antigen
stimul
result
cell
exhaust
mirror
decreas
effector
function
prolif
capac
tex
manifest
overexpress
inhibitori
receptor
includ
lymphoid
cell
surfac
protein
ig
superfamili
member
extend
famili
cell
regul
act
matur
cell
checkpoint
modul
apoptosi
interact
either
ligand
member
famili
cell
coreceptor
includ
constitut
signific
neg
immun
informat
checkpoint
pathway
respons
blunt
cellmedi
immun
respons
specif
respons
upregul
result
patholog
eg
malign
develop
monoclon
antibodi
peptidebas
nonpeptid
smallmolecul
inhibitor
pathway
hold
strong
promis
effect
benefici
immunodul
immun
surveil
blockad
pathway
subpopul
vitro
vivo
open
new
therapeut
avenu
abrog
function
exhaust
cell
reinstat
vigor
cell
cytotox
viral
antigen
reinvegor
tex
may
also
obtain
restor
effect
costimul
sinc
appear
directli
target
cytoplasm
tail
conclus
acquir
cellular
immun
surveil
fine
regul
set
process
event
involv
specif
popul
subpopul
lymphocyt
cell
princip
respons
cytotox
clearanc
viral
infect
tumor
cell
one
compon
regulatori
arm
cellular
immun
result
exhaust
cell
tex
primarili
popul
emerg
chronic
highgrad
viral
infect
observ
tex
broadli
divid
subset
initi
intermedi
stage
tex
lowmedium
retain
quasinorm
mitochondri
spare
respiratori
capac
src
gener
respons
blockad
kind
outlin
advanc
stage
tex
ad
high
lower
mitochondri
src
termin
exhaust
larg
unrespons
checkpoint
blockad
immunotherapi
broadli
speak
express
tex
parallel
well
product
tnfa
cytokin
modul
express
either
mediat
apoptot
cytopaenia
patient
short
evid
tex
date
lend
consider
clinic
relev
preliminari
observ
report
diao
collabor
data
point
signific
cytopoenia
circul
cell
patient
confirm
serum
patient
significantli
elev
level
tnfa
analys
show
progress
increas
subpopul
patient
deterior
prodrom
symptomat
requir
intens
care
taken
togeth
report
profil
suggest
emerg
tex
patient
confirm
find
replic
would
behoov
clinic
research
scientist
develop
diagnost
protocol
includ
flow
cytometr
assess
good
measur
subpopul
patient
predominantli
lowmedium
enter
vigor
immunotherapeut
protocol
design
restor
cytotox
potenti
block
pathway
andor
pathway
contrast
palli
care
proffer
patient
high
tex
like
overwhelm
cellular
immun
surveil
unclear
time
whether
two
identifi
subset
tex
differenti
modul
gonad
hormon
say
whether
estrogen
testosteron
affect
inter
mediat
stage
advanc
stage
tex
differenti
tex
matter
clinic
epidemiolog
observ
date
indic
men
suscept
women
data
also
show
elderli
significantli
risk
younger
patient
popul
possibl
therefor
exam
problem
tex
exacerb
immunosenesc
also
content
ai
algorithm
type
describ
previous
found
relev
context
particular
import
could
yield
clinic
import
benefit
immunopatholog
diagnost
patient
afflict
direct
immunotherapeut
intervent
case
point
special
ai
algorithm
could
establish
mean
protocol
restor
cell
homeostasi
immunosenesc
cell
exhaust
key
develop
new
improv
immunotherapi
particular
patient
case
point
special
ai
algorithm
could
establish
mean
protocol
restor
cell
homeostasi
immunosenesc
cell
exhaust
key
develop
new
improv
immunotherapi
particular
patient
